567-Patient Study Confirms LMWH Safety in Pregnancy
Flora Peyvandi, former President of ISTH, recently shared an insightful post on X:
”The Risk of Bleeding in Pregnant Women with Acute Venous Thromboembolism Treated with Anticoagulants: An International Multi-Database Cohort Study.”
Read the full article here.
An article ”The Risk of Bleeding in Pregnant Women with Acute Venous Thromboembolism Treated with Anticoagulants: An International Multi-Database Cohort Study”, published by Camille Simard et al. in the Journal of Thrombosis and Haemostasis, sheds light on the safety use of low-molecular-weight heparin (LMWH) in pregnancy complicated by acute venous throembolism.
This multinational (Germany;Quebec) cohort study of 567 pregnant women with VTE treated with LMWH provided new data on bleeding risk during pregnancy.
The findings suggest that LMWH type and dosing frequency may not significantly impact bleeding risk, though further research is needed to refine anticoagulation strategies for optimizing maternal outcomes.
More on scientific advancements in the field of thrombosis featured in Hemostasis Today.
-
Dec 8, 2025, 15:09Paul Bolaji Invites You to Nigerian Stroke Leaders’ Summit 2025
-
Dec 8, 2025, 14:58Mohammad E Barbati on ClotTriever System for Postpartum Iliofemoral DVT
-
Dec 8, 2025, 14:46Jean Jacques Kiladjian Presents 1st Results of the ROP-ET Study at ASH25
-
Dec 8, 2025, 11:23Jorge Di Paola and Diane Krause Take Their Awards at ASH25
-
Dec 8, 2025, 11:08Andreas Tiede: This Will Change Hematology Forever
-
Dec 8, 2025, 09:39Asfand Yar Cheema Honored with Abstract Achievement Awards at ASH25
-
Dec 8, 2025, 09:27Ana Rita Rodrigues on the Impact of Post-Stroke Dysphagia
-
Dec 8, 2025, 09:19Sanam Loghavi and Shannon McWeeney at Joint Session on AI nad Hematology at ASH25
-
Dec 7, 2025, 18:43ASH25 Day 2: Don’t Miss The Highlights